1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 17 AUGUST 2015

CNS Drug News 17 AUGUST 2015

  • August 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Amended Contrave Agreement Will Restore Working Relationship
Industry Trend Analysis - Glatopa And Biosimilars Will Be Increasingly Important For Sandoz
Industry Trend Analysis - Teva To Maintain Dominance In Global Generics
Industry Trend Analysis - Synthon's Glatiramer Promises Rich Rewards For Pfizer
Industry Brief - Enrolment Completed In Phase IIa Trial Of ATX-MS-1467 For Relapsing MS
Industry Brief - FDA Accepts Teva's NDA Filing For SD-809 In HD
Industry Brief - FDA Accepts Brintellix sNDA To Review Cognitive Effects In MDD
Industry Brief - FDA Reinstates Bioequivalence Requirements For Intellipharmaceutics' Dexmethylphenidate
Industry Brief - Aegis Granted Patents For Non-Invasive Delivery Of Triptan Antimigraine Drugs
Industry Brief - Mylan Launches Lidocaine Patch In US
Industry Brief - PAION Initiates EU Phase III Study Of Remimazolam In General Anaesthesia
Industry Trend Analysis - New Zubsolv Indication Will Improve Platform In A Static Market
Industry Brief - SAGE/FDA Reach SPA Agreement On SAGE-547 Phase III Trial In SRSE
Industry Brief - First Patient Treated In SAGE-547 Phase III Trial In SRSE
Industry Brief - Orexigen/Kwang Dong Sign South Korea Contrave Distribution Deal
Industry Brief - Boehringer Ingelheim And Circuit Therapeutics Enter Obesity Collaboration
Industry Brief - Neurocrine Completes Enrolment In NBI-98854 Phase III TD Study
Industry Brief - Pfizer's Recombinant IVIG Receives ODD For Rare Neurological Disorder
Industry Trend Analysis - Genomic Analysis Will Bring Success To CNS Pipelines
Industry Brief - Depomed Board Rejects Horizon's Revised Proposal
Industry Trend Analysis - Divesting Allergan's Generics Business Will Increase Pressure On CNS Franchise
Industry Brief - Ovid Therapeutics Completes Oversubscribed USD75mn Series B Financing
Industry Brief - CNS Conferences - November 2015

Table Of Contents

CNS Drug News 17 AUGUST 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

  • $ 10995
  • Industry report
  • October 2016
  • by Global Data

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. It is characterized ...

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorder is characterized ...

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Europe Neurological Disorder Drugs Market: Overview This report on the neurological disorder drugs market studies the current as well as future prospects of the market in Europe. Health concern related ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.